Entero Therapeutics, Inc.
Entero Therapeutics, Inc. (ENTO) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 3 transactions totaling $2.0K, demonstrating a bearish sentiment with -$2.0K in net insider flow. The most recent transaction on Jul 2, 2024 involved a sale of 1,289 shares valued at $1.4K.
ENTO Insider Activity Summary
Who Is Buying ENTO Stock?
No significant insider buying has been recorded for ENTO in the recent period.
Who Is Selling ENTO Stock?
No significant insider selling has been recorded for ENTO in the recent period.
Is Entero Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ENTO is bearish with an Insider Alignment Score of 0/100 and a net flow of -$2.0K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ENTO Frequently Asked Questions
Understanding ENTO Insider Activity
Insider trading at Entero Therapeutics, Inc. (ENTO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading ENTO stock, having executed 3 transactions in the past 90 days. The most active insider is James Sapirstein (Executive), who has made 1 transactions totaling $1.4K.
Related Tools
Track Entero Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ENTO file new Form 4 transactions